Independent Review Report for Teriparatide

Teriparatide - Independent Review of PBAC Submissions by Eli Lilly Australia

Page last updated: 02 March 2007

PDF printable version Teriparatide Independent Review - PDF 263 KB

Generic Name: Teriparatide (Rbe) Injection

Trade Name: Forteo ®

Company Sponsor: Eli Lilly Australia Pty Ltd

Content: Independent review of matters identified by the sponsor in relation to PBAC decisions not to list Teriparatide for the treatment of severe osteoporosis

The names of reviewers have been withheld, consistent with PBAC procedures

Date: 7 September 2006